Ohm spoke earlier of a certain lack of trust in an
Post# of 148109
Summit Therapeutics just slapped the face of Keytruda...in lung Cancer from a phase 3 Study.
The Study conducted in China by Summits Partner AKESO...raised Summits market cap by $5 Billion.